Just a moment...
We've upgraded AI Search on TaxTMI with two powerful modes:
1. Basic
• Quick overview summary answering your query with references
• Category-wise results to explore all relevant documents on TaxTMI
2. Advanced
• Includes everything in Basic
• Detailed report covering:
- Overview Summary
- Governing Provisions [Acts, Notifications, Circulars]
- Relevant Case Laws
- Tariff / Classification / HSN
- Expert views from TaxTMI
- Practical Guidance with immediate steps and dispute strategy
• Also highlights how each document is relevant to your query, helping you quickly understand key insights without reading the full text.
Help Us Improve - by giving the rating with each AI Result:
Powered by Weblekha - Building Scalable Websites
Press 'Enter' to add multiple search terms. Rules for Better Search
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
TP adjustment of interest - CIT(A) confirmed upward adjustment towards interest by adopting rupee loan rate instead of LIBOR linked rate in respect of foreign currency loans advanced to subsidiary. Adjustment in respect of Corporation Bank interest and Allahabad Bank interest deleted as amount was not advanced to AE for entire period. Loan granted to AE out of own funds - matter remitted to AO for readjudication of adjustment of interest. Deduction u/s 35(2AB) - claim for weighted deduction on gross R&D expenditure allowed without reducing contract research income. TP adjustment of corporate guarantee fee - adjustment restricted at 0.5% on guarantee amount. Disallowance u/s 36(1)(iii) - interest free advance - disallowance deleted due to sufficient interest free funds. Excess claim u/s 35(2AB) over DSIR approval - deduction allowed on actual expenditure prior to amendment. Additional claim of weighted deduction u/s 35(2AB) on clinical trial expenses - matter remitted back.